Company Filing History:
Years Active: 2010-2019
Title: I-Ju Liu: Innovator in Cancer Research and SARS Diagnosis
Introduction
I-Ju Liu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the fields of cancer research and infectious disease diagnosis. With a total of 2 patents, Liu's work focuses on innovative methods for detecting and treating serious health conditions.
Latest Patents
Liu's latest patents include groundbreaking inventions such as an anti-vascular endothelial growth factor receptor 2 (VEGFR2) antibody. This antibody is designed for detecting VEGFR2 and inhibiting tumor growth, tumor angiogenesis, and inducing cancer cell cytotoxicity. The patent details an isolated antibody or an antigen-binding fragment that specifically binds to an epitope within the domain 1 or domain 3 of human VEGFR2. Additionally, Liu has developed a method for detecting the presence of VEGFR2 in tumor vascular endothelial cells or cancer cells in biological samples. Another notable patent involves SARS-CoV-specific B-cell epitopes, which can be synthesized or expressed in phages for accurate diagnosis of SARS patients. These peptides offer high sensitivity and specificity for serologic detection, making them potential immunogens for antibody production against SARS.
Career Highlights
Throughout his career, I-Ju Liu has worked with esteemed institutions such as Academia Sinica and National Taiwan University. His research has significantly advanced the understanding of cancer biology and infectious diseases, contributing to the development of effective diagnostic tools and therapeutic strategies.
Collaborations
Liu has collaborated with notable colleagues, including Han-Chung Wu and Ruei-Min Lu. Their joint efforts have further enhanced the impact of Liu's research in the scientific community.
Conclusion
I-Ju Liu's innovative work in cancer research and SARS diagnosis exemplifies the importance of scientific advancements in healthcare. His patents reflect a commitment to improving diagnostic methods and treatment options for critical health issues.